About: Charity Morgan

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Charity Morgan Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	forskare (sv) researcher (en) 연구원 (ko) 研究者 (ja) araştırmacı (tr) wetenschapper (nl) дослідник (uk) эрдэмтэн (mn) изилдөөчү (ky) 研究者 (zh) հետազոտող (hy)
rdfs:label	Charity J Morgan (ga) Charity Morgan (en) Charity Morgan (es) Charity Morgan (nl) Charity Morgan (sl) Charity Morgan (ast)
skos:prefLabel	Charity J Morgan (ga) Charity Morgan (en) Charity Morgan (es) Charity Morgan (nl) Charity Morgan (sl) Charity Morgan (ast)
name	Charity J Morgan (ga) Charity Morgan (en) Charity Morgan (es) Charity Morgan (nl) Charity Morgan (sl) Charity Morgan (ast)
Scopus author ID	wds:Q50643864-C09F6C8A-7481-44C2-8877-8AAECD87E0E3
Scopus author ID	36143272700
given name	wds:Q50643864-8E711A16-63B7-4E40-9200-D8F9D56C8C52 wds:Q50643864-C48A05BB-3100-484A-90B0-92AEEFEA4AAC
given name	Charity Johanna
instance of	wds:Q50643864-48D15A02-A6B0-4B95-89E4-BFF989502965
instance of	Homo sapiens
doctoral advisor	wds:Q50643864-72E34056-FAD6-4E2A-9D84-252A1480096E
Academic Tree ID	wds:Q50643864-8b36774f-4916-8639-f9af-5df25fe96e05
Google Knowledge Graph ID	wds:Q50643864-46B2AA98-1B68-4C3D-9DC4-DD0AA2EDD7D4
MR Author ID	wds:Q50643864-B3E33DE5-CBCF-4817-8183-D33E7B8B22A0
Mathematics Genealogy Project ID	wds:Q50643864-321D2070-0108-4D40-A95C-1096D7FF8F02
Google Knowledge Graph ID	http://g.co/kg/g/11g0lgx0t3
doctoral advisor	Donald B. Rubin
Academic Tree ID	230233
Google Knowledge Graph ID	/g/11g0lgx0t3
MR Author ID	1056115
Mathematics Genealogy Project ID	193496
ResearchGate profile ID	wds:Q50643864-f5d2e0d8-4368-5fa6-3f3e-43f2151d33c8
ResearchGate profile ID	Charity-Morgan
skos:altLabel	Charity J Morgan (en) Charity J Morgan (nl)
occupation	wds:Q50643864-B8AB1B55-9070-47F2-93E6-F930C3890EA5
employer	wds:Q50643864-D648CAC6-46F6-4578-A3B2-730909641283 wds:Q50643864-F074C5B3-DBFB-4F0B-9C37-E06540D17DA3
sex or gender	wds:Q50643864-EA6B019E-5434-4719-B7D2-8AEEAF0FA03D
educated at	wds:Q50643864-4C6CD1E6-B95C-41AE-B145-BA7A35AA980B wds:Q50643864-6BADE948-CFC9-4899-879F-3C809AA539FD
family name	wds:Q50643864-5EFFE527-1C44-489A-A89A-93DCF38A3C09
occupation	biostatistician
employer	Food and Drug Administration University of Alabama at Birmingham
sex or gender	female organism
educated at	Washington University in St. Louis Harvard University
family name	Morgan
ORCID iD	wds:Q50643864-101B7FE6-5EBD-4453-B2B1-334B248DD708
ORCID iD	https://orcid.org/0000-0003-0693-4739
ORCID iD	0000-0003-0693-4739
is owl:sameAs of	Charity Morgan
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q50643864
is author of	A hierarchical finite mixture model that accommodates zero-inflated counts, non-independence, and heterogeneity Pancreatitis with vascular endothelial growth factor receptor tyrosine kinase inhibitors Wide variation in the multiplicity of HIV-1 infection among injection drug users Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failure Digoxin and 30-day all-cause hospital admission in older patients with chronic diastolic heart failure High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men. Characteristics and outcomes of patients with advanced chronic systolic heart failure receiving care at the Veterans Affairs versus other hospitals: insights from the Beta-blocker Evaluation of Survival Trial (BEST) Methods for evaluating the agreement between diagnostic tests Congestive heart failure with vascular endothelial growth factor receptor tyrosine kinase inhibitors Infections, Arrhythmias, and Hospitalizations on Home Intravenous Inotropic Therapy Impact of prednisone on toxicities and survival in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis of randomized clinical trials Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure. Breast cancer subtypes predispose the site of distant metastases. Vitamin D deficiency and incident stroke risk in community-living black and white adults Meta-analysis of regression of advanced solid tumors in patients receiving placebo or no anti-cancer therapy in prospective trials Impact of atrial fibrillation and heart failure, independent of each other and in combination, on mortality in community-dwelling older adults Conducting and interpreting high-quality systematic reviews and meta-analyses Calcium channel blockers and outcomes in older patients with heart failure and preserved ejection fraction Clinical Characteristics and Outcomes of Intravenous Inotropic Therapy in Advanced Heart Failure Discharge Hospice Referral and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries Hospitalized for Heart Failure Effect of African-American Race on Tumor Recurrence After Radical Cystectomy for Urothelial Carcinoma of the Bladder Statistical issues associated with terminating a clinical trial due to slow enrollment Risperidone Effects on Brain Dynamic Connectivity-A Prospective Resting-State fMRI Study in Schizophrenia One- to 10-Day Versus 11- to 30-Day All-Cause Readmission and Mortality in Older Patients With Heart Failure Reducing bias using propensity score matching. Hydrophilic vs lipophilic statins in coronary artery disease: A meta-analysis of randomized controlled trials Digoxin use and lower risk of 30-day all-cause readmission in older patients with heart failure and reduced ejection fraction receiving β-blockers.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software